HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Actin related protein 3 (ARP3) promotes apoptosis of intestinal epithelial cells in ulcerative colitis.

Abstract
Apoptosis in intestinal epithelial cells (IECs) promotes the development of ulcerative colitis (UC), a type of inflammatory bowel disease (IBD). Efficient clearance of apoptotic cells is essential for tissue homeostasis in metazoans. Actin related protein 3 (ARP3) promotes endothelial dysfunction. The expression and function of ARP3 in UC remains unclear. In this study, the expression of apoptotic markers as p53, Bax, Cleaved-Caspease9 and Cleaved-Caspease3 were proved to be increased in the intestinal epithelial cells (IECs) of UC patients and in a mouse disuccinimidyl suberate(DSS)-induced colitis model; meanwhile, ARP3 expression was elevated. ARP3 expression levels and the severity of symptoms in patients with UC were positively correlated. By knocking down ARP3 in a TNF-α-treated NCM-460 cell colitis model, the apoptotic markers described above were all decreased. In conclusion, our data indicates that ARP3 might promote the apoptosis of IECs in UC, revealing a potential molecular target for treating UC.
AuthorsShi-Qing Zhang, Wen-Kai Ni, Ming-Bing Xiao, Feng Jiang, Cui-Hua Lu, Rui-Hua Wang, Run-Zhou Ni
JournalPathology, research and practice (Pathol Res Pract) Vol. 215 Issue 2 Pg. 235-242 (Feb 2019) ISSN: 1618-0631 [Electronic] Germany
PMID30396755 (Publication Type: Journal Article)
CopyrightCopyright © 2018 Elsevier GmbH. All rights reserved.
Chemical References
  • Actin-Related Protein 3
Topics
  • Actin-Related Protein 3 (metabolism)
  • Animals
  • Apoptosis (physiology)
  • Cell Line
  • Colitis, Ulcerative (metabolism, pathology)
  • Epithelial Cells (metabolism, pathology)
  • Humans
  • Intestinal Mucosa (metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: